Achieve Life Sciences
ACHV
17 hedge funds and large institutions have $978K invested in Achieve Life Sciences in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
13% more funds holding
Funds holding: 15 → 17 (+2)
0.34% less ownership
Funds ownership: 0.78% → 0.45% (-0.34%)
55% less capital invested
Capital invested by funds: $2.16M → $978K (-$1.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.25M |
| 2 |
Renaissance Technologies
New York
|
+$111K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$28.7K |
| 4 |
Goldman Sachs
New York
|
+$13.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$892K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$175K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$63K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$32K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$24K |
ACHV Hedge Fund Activity: Q4 2019 in Review
17 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2019, worth a combined $978K — down 55% from $2.16M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ACHV positions and 7 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $1.25M. The largest seller was Sio Capital Management, exiting entirely with an estimated $892K sold.
- 17 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2019, up from 15 in Q3 2019.
- Funds reported $978K of Achieve Life Sciences stock for Q4 2019, down 55% quarter-over-quarter.
- 9 funds opened new Achieve Life Sciences positions in Q4 2019 and 7 closed out, a net change of +2 holders.
- The largest Achieve Life Sciences buyer in Q4 2019 was CVI Holdings, an estimated $1.25M added.
- The largest Achieve Life Sciences seller in Q4 2019 was Sio Capital Management, an estimated $892K sold.
Based on aggregated 13F filings for Q4 2019.